BLK
61
-2
FCX
57
-2
WU
34
-2
KHC
20
2
UPS
61
-3
URBN
50
-2
CF
56
3
MCHP
43
-11
AIV
74
2
PNW
70
3
WAT
64
7
VFC
50
-2
XRX
42
-3
ADI
51
-3
GME
70
2
NWSA
63
-4
ED
55
3
SPG
63
7
BEN
48
-4
ETR
72
3
BLK
61
-2
FCX
57
-2
WU
34
-2
KHC
20
2
UPS
61
-3
URBN
50
-2
CF
56
3
MCHP
43
-11
AIV
74
2
PNW
70
3
WAT
64
7
VFC
50
-2
XRX
42
-3
ADI
51
-3
GME
70
2
NWSA
63
-4
ED
55
3
SPG
63
7
BEN
48
-4
ETR
72
3
Financhill
Back

Grupo Televisa SAB 10K Form

Sell
21

TV
Grupo Televisa SAB

Last Price:
1.96
Seasonality Move:
3.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TV News And Ratings

See the #1 stock for the next 7 days that we like better than TV

TV Financial Statistics

Sales & Book Value

Annual Sales: $4.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $10.75
Price / Book: 0.18

Profitability

EPS (TTM): 17.92800
Net Income (TTM): $-300.2M
Gross Margin: $1.4B
Return on Equity: -4.1%
Return on Assets: -2.04%

Grupo Televisa SAB Earnings Forecast

Key Grupo Televisa SAB Financial Ratios

  • The Gross Profit Margin over the past 30 years for TV is 33.71%.
  • The Selling, General & Administrative Expenses for TV have been equal to 28.84% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -90.88% of Operating Income.
  • The Net Earning history of TV is -11.42% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 14 years.

Grupo Televisa SAB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Media
Sector: Communication Services
Current Symbol: TV
CUSIP: 40049J
Website: televisa.com

Debt

Debt-to-Equity Ratio: 0.87
Current Ratio: 2.43
Quick Ratio: 2.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TV Technical Analysis vs Fundamental Analysis

Sell
21
Grupo Televisa SAB (TV) is a Sell

Is Grupo Televisa SAB a Buy or a Sell?

  • Grupo Televisa SAB stock is rated a Sell
    The current Grupo Televisa SAB [TV] share price is $1.96. The Score for TV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.